Oyekunle Emmanuel O, Akinlade Bidemi I, Jimoh Mutiu A
Department of Radiation Oncology, University College Hospital, Ibadan, Nigeria.
Department of Radiation Oncology, College of Medicine, University College Hospital, Ibadan, Nigeria.
J Appl Clin Med Phys. 2018 Jul;19(4):68-74. doi: 10.1002/acm2.12341. Epub 2018 May 13.
Source strength (S ), sizes of vaginal cylinder applicators (VCA), number of dwell positions (DPs), and the prescribed dose (D) are basic parameters in brachytherapy (BT) treatment planning contributing to total dwell time (TDT). This study was aimed at assessing the relationships between the specified variables in an attempt to verify the TDT in high-dose-rate (HDR) vaginal cylinder applications.
One hundred and twenty-one patients treated with Gynesource-Co (Bebig, Germany) using VCAs of diameters 20, 25, and 30 mm at University College Hospital, Nigeria, were enrolled in this study. Brachytherapy doses ranging from 3 to 7 Gy were always prescribed to points 5 mm away from the cylinder's surface. Treatment planning was undertaken on HDR-Basic treatment planning system (TPS) which utilizes source step size of 5 mm. Data on the stated parameters related to the first BT fractions of the patients were acquired. With the aid of EViews statistical software, two forms of mathematical models were thereafter developed. The resulting TDTs from the models were compared with the TPS values using Minitab statistical software.
The relationships obtained for the increasing sizes of the VCA were TDT1(min)=2.22+3.17DSk;TDT1(min)=3.52+3.74DSk;TDT1(min)=-1.96+6.91DSkandTDT2(min)=0.50-0.03Sk+0.02D+0.55DPs;TDT2(min)=7.08-0.06Sk+0.02D+0.67DPs;TDT2(min)=7.02-0.11Sk+0.03D+1.25DPs The model-based TDTs correlate with the TPS-calculated values with r = 0.80 (P = 0.412) and r = 0.97 (P = 0.468).
The findings of this study could suggest likely variations in the treatment time when certain changes occur in the related parameters. The increasing size of the vaginal cylinder has a positive influence on the brachytherapy treatment time. The latter model has been a useful tool in the verification of the dose delivery time at the first HDR brachytherapy center in Nigeria and West Africa.
源强(S)、阴道柱状施源器尺寸(VCA)、驻留位置数量(DPs)和处方剂量(D)是近距离放射治疗(BT)治疗计划中的基本参数,这些参数会影响总驻留时间(TDT)。本研究旨在评估特定变量之间的关系,以验证高剂量率(HDR)阴道柱状施源器应用中的TDT。
在尼日利亚大学学院医院,对121例使用直径为20、25和30mm的VCA进行Gynesource-Co(德国贝比格公司)治疗的患者进行了研究。总是将3至7Gy的近距离放射治疗剂量处方给距离施源器表面5mm处的点。在使用5mm源步长的HDR - Basic治疗计划系统(TPS)上进行治疗计划。获取了与患者首次BT分次相关的上述参数的数据。此后,借助EViews统计软件开发了两种数学模型。使用Minitab统计软件将模型得出的TDT与TPS值进行比较。
VCA尺寸增大时得到的关系为:TDT1(min)=2.22 + 3.17DSk;TDT1(min)=3.52 + 3.74DSk;TDT1(min)=-1.96 + 6.91DSk以及TDT2(min)=0.50 - 0.03Sk + 0.02D + 0.55DPs;TDT2(min)=7.08 - 0.06Sk + 0.02D + 0.67DPs;TDT2(min)=7.02 - 0.11Sk + 0.03D + 1.25DPs。基于模型的TDT与TPS计算值相关,r = 0.80(P = 0.412)和r = 0.97(P = 0.468)。
本研究结果可能表明,当相关参数发生某些变化时,治疗时间可能会有所不同。阴道柱状施源器尺寸的增加对近距离放射治疗时间有积极影响。后一种模型是尼日利亚和西非首个HDR近距离放射治疗中心验证剂量输送时间的有用工具。